SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-214241
Filing Date
2024-09-05
Accepted
2024-09-05 16:35:57
Documents
14
Period of Report
2024-09-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d888247d8k.htm   iXBRL 8-K 41629
  Complete submission text file 0001193125-24-214241.txt   202591

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20240903.xsd EX-101.SCH 4130
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20240903_def.xml EX-101.DEF 13697
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20240903_lab.xml EX-101.LAB 22771
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20240903_pre.xml EX-101.PRE 14665
16 EXTRACTED XBRL INSTANCE DOCUMENT d888247d8k_htm.xml XML 5887
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 241281866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)